MILL VIEW SURGERY — All Prescriptions & Medications — Page 6
Practice Code: M83641 | UTTOXETER, ST14 5JX
Showing results 251-300 of 339
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 20 | 850 | £3.2K | +63.1% ▲ | |
| Midodrine hydrochloride | 19 | 1,344 | £286 | -61.0% ▼ |
| Prasugrel | 19 | 532 | £80 | -39.5% ▼ |
| Tranexamic acid | 19 | 1,098 | £79 | -77.6% ▼ |
| Metoclopramide hydrochloride | 19 | 519 | £19 | -77.1% ▼ |
| Oxytetracycline | 19 | 616 | £196 | -26.4% ▼ |
| Erythromycin ethylsuccinate | 19 | 2,400 | £237 | -18.6% ▼ |
| Estradiol valerate | 19 | 1,092 | £84 | -2.7% ▼ |
| Norethisterone | 19 | 633 | £108 | -60.8% ▼ |
| 19 | 950 | £54 | -72.8% ▼ | |
| Timolol and bimatoprost | 18 | 75 | £281 | -88.1% ▼ |
| Coal tar | 18 | 4,500 | £87 | -75.3% ▼ |
| 18 | 351 | £77 | -54.3% ▼ | |
| Safinamide | 17 | 119 | £262 | -15.6% ▼ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 17 | 122.5K | £2.2K | -75.7% ▼ |
| Permethrin | 17 | 690 | £282 | -54.9% ▼ |
| 17 | 200 | £52 | +24.4% ▲ | |
| 17 | 8,730 | £114 | -93.6% ▼ | |
| 17 | 2,000 | £346 | +69.2% ▲ | |
| Balsalazide sodium | 16 | 2,860 | £615 | +7.4% ▲ |
| Pancreatin | 16 | 3,948 | £1.3K | -85.6% ▼ |
| Metoprolol tartrate | 16 | 728 | £88 | -68.5% ▼ |
| Empagliflozin | 16 | 448 | £529 | -97.4% ▼ |
| Fludrocortisone acetate | 16 | 294 | £77 | -84.8% ▼ |
| Other individually formulated bought in preparations | 16 | 1,402 | £132 | -51.0% ▼ |
| Oxcarbazepine | 15 | 972 | £411 | -46.4% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 15 | 1,700 | £122 | -90.1% ▼ |
| Dulaglutide | 15 | 72 | £1.2K | -86.9% ▼ |
| 15 | 150 | £18 | -60.1% ▼ | |
| 15 | 27 | £166 | -58.0% ▼ | |
| Metronidazole | 14 | 253 | £11 | -78.7% ▼ |
| Insulin Lispro | 14 | 92 | £508 | -81.7% ▼ |
| Insulin glulisine | 14 | 120 | £613 | -34.7% ▼ |
| Water for injection | 14 | 250 | £75 | -58.6% ▼ |
| RtS 1.5 - 1.6 kcal/ml milkshake with fibre (0913011) | 14 | 172.0K | £2.5K | +5.3% ▲ |
| Tube feed 1 kcal/ml with fibre (0914011) | 14 | 200.0K | £3.3K | +35.6% ▲ |
| 14 | 1,710 | £3.3K | -64.9% ▼ | |
| 14 | 180 | £469 | -70.7% ▼ | |
| 14 | 840 | £232 | -45.7% ▼ | |
| Amantadine hydrochloride | 13 | 924 | £226 | -53.3% ▼ |
| Azathioprine | 13 | 700 | £16 | -88.0% ▼ |
| Magnesium glycerophosphate | 13 | 1,700 | £777 | -5.4% ▼ |
| Tafluprost | 13 | 390 | £156 | -29.9% ▼ |
| Clobetasone butyrate | 13 | 810 | £42 | -93.6% ▼ |
| Midazolam hydrochloride | 13 | 120 | £66 | -68.2% ▼ |
| 13 | 45 | £559 | +153.3% ▲ | |
| Carvedilol | 12 | 672 | £28 | -89.4% ▼ |
| Colestyramine | 12 | 582 | £159 | -58.3% ▼ |
| Hydroxyzine hydrochloride | 12 | 672 | £17 | -77.5% ▼ |
| Imipramine hydrochloride | 12 | 952 | £37 | -52.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.